INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1–mediated lysosomal exocytosis
Journal of Cell Biology · 2024
DOI: 10.1083/jcb.202401012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Golam T Saffi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Cell Movement, Exocytosis, Lysosomes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Canada Research Chairs, University of Toronto, Human Frontier Career Development Program.
Abstract (Originalsprache)
Aggressive solid malignancies, including pancreatic ductal adenocarcinoma (PDAC), can exploit lysosomal exocytosis to modify the tumor microenvironment, enhance motility, and promote invasiveness. However, the molecular pathways through which lysosomal functions are co-opted in malignant cells remain poorly understood. In this study, we demonstrate that inositol polyphosphate 4-phosphatase, Type II (INPP4B) overexpression in PDAC is associated with PDAC progression. We show that INPP4B overexpression promotes peripheral dispersion and exocytosis of lysosomes resulting in increased migratory and invasive potential of PDAC cells. Mechanistically, INPP4B overexpression drives the generation of PtdIns(3,5)P2 on lysosomes in a PIKfyve-dependent manner, which directs TRPML-1 to trigger the release of calcium ions (Ca2+). Our findings offer a molecular understanding of the prognostic significance of INPP4B overexpression in PDAC through the discovery of a novel oncogenic signaling axis that orchestrates migratory and invasive properties of PDAC via the regulation of lysosomal phosphoinositide homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
- Department of Chemistry and Biology, Toronto Metropolitan University, Toronto, Canada.
- PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research , Toronto, Canada.
- Princess Margaret Cancer Centre, University Health Network , Toronto, Canada.
ORCID-Profile: Golam T Saffi, Lydia To, Nicholas Kleine, Ché M P Melo, Keyue Chen, Gizem Genc, K C Daniel Lee, Jonathan Tak-Sum Chow, Gun Ho Jang, Steven Gallinger, Roberto J Botelho, Leonardo Salmena
Förderung
- Canada Research Chairs
- University of Toronto
- Human Frontier Career Development Program
- Canada Foundation for Innovation
- Cancer Research Society
- Canadian Institute of Health Research
- Natural Sciences and Engineering Council of Canada
- Toronto Metropolitan University
Zitieren
APA
Saffi, G. T., To, L., Kleine, N., Melo, C. M. P., Chen, K., Genc, G., Lee, K. C. D., Chow, J. T., Jang, G. H., Gallinger, S., Botelho, R. J., & Salmena, L. (2024). INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1–mediated lysosomal exocytosis. Journal of Cell Biology. https://doi.org/10.1083/jcb.202401012
Vancouver
Saffi GT, To L, Kleine N, Melo CMP, Chen K, Genc G, et al. INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1–mediated lysosomal exocytosis. Journal of Cell Biology. 2024. doi:10.1083/jcb.202401012
BibTeX
@article{Saffi2024,
author = {Saffi, Golam T and To, Lydia and Kleine, Nicholas and Melo, Ché M P and Chen, Keyue and Genc, Gizem and Lee, K C Daniel and Chow, Jonathan Tak-Sum and Jang, Gun Ho and Gallinger, Steven and Botelho, Roberto J and Salmena, Leonardo},
title = {INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1–mediated lysosomal exocytosis},
journal = {Journal of Cell Biology},
year = {2024},
doi = {10.1083/jcb.202401012}
}
EUVIMED